Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (SHE:300255)

China flag China · Delayed Price · Currency is CNY
39.15
-0.65 (-1.63%)
Apr 28, 2026, 3:04 PM CST
90.23%
Market Cap 35.98B
Revenue (ttm) 928.01M
Net Income (ttm) -301.59M
Shares Out 919.06M
EPS (ttm) -0.29
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 14,015,705
Average Volume 26,500,637
Open 39.68
Previous Close 39.80
Day's Range 38.92 - 40.22
52-Week Range 20.23 - 71.71
Beta 0.35
RSI 39.03
Earnings Date Apr 29, 2026

About SHE:300255

Hebei Changshan Biochemical Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of crude heparin, heparin raw materials, and heparin preparations for the treatment of cardiovascular and cerebrovascular diseases in China and internationally. The company offers crude heparin sodium, heparin sodium API, heparin sodium injections, low molecular weight heparin calcium injections, enoxaparin sodium injections, nandroparin calcium injection, dalteparin sodium API and injections, and other products. The company was found... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2000
Employees 1,254
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300255
Full Company Profile

Financial Performance

In 2024, SHE:300255's revenue was 1.03 billion, a decrease of -26.92% compared to the previous year's 1.41 billion. Losses were -249.48 million, -79.88% less than in 2023.

Financial Statements

News

There is no news available yet.